India Exchange Filings

Orchid Pharma Q2 FY27 Investor Presentation

Orchid Pharma Ltd reports Q2 FY27 standalone revenue of ₹341.27 crore, up 14% year on year

  • EBITDA was ₹52 crore, with a 15% operating margin.
  • Net profit rose 432% year on year to ₹36.76 crore; no exceptional items were reported.
  • Presentation covered the completed amalgamation of Dhanuka Laboratories and business-development initiatives for EXBLIFEP.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.